Insulet Corporation(PODD)Earnings, Financials & Key RatiosInsulet Corporation (PODD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company shows strong top-line growth of 33.9% and a healthy current ratio of 2.49, the erratic free cash flow conversion and high capital expenditure requirements, which peaked at 19.1% of revenue in 2025Q4, warrant a cautious wait-and-see approach.
Insulet Corporation (PODD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Insulet Corporation (PODD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $1.42vs $1.19+19.3% | $762Mvs $730M+4.4% |
| Q1 2026 | Feb 18, 2026 | $1.55vs $1.47+5.4% | $784Mvs $769M+1.9% |
| Q4 2025 | Nov 6, 2025 | $1.24vs $1.14+8.8% | $706Mvs $678M+4.1% |
| Q3 2025 | Aug 7, 2025 | $1.17vs $0.92+27.2% | $649Mvs $614M+5.7% |
Recent stock market news and headlines for Insulet Corporation (PODD)
The U.S. Food and Drug Administration (FDA) has designated Insulet Corp.'s (NASDAQ:PODD) recall of certain Omnipod insulin delivery pods as a Class I recall, the agency's most serious classification, warning that continued use of affected devices could result in serious injury or death.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before the opening of the financial markets. In connection with the release, management will host a conference call that day at 8:00 a.m. (Eastern Time). The link to the live call will be available on the I.
Investors need to pay close attention to PODD stock based on the movements in the options market lately.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Jonathan (“Jay”) Mazelsky to the Company's Board of Directors, effective July 1, 2026. Mr. Mazelsky joins the Board as an independent director. “We are pleased to welcome Jay to Insulet's Board of Directors,” said President and CEO Ashley McEvoy. “Jay has a strong track record of.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Key metrics vs top competitors for Insulet Corporation (PODD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $159.77 | $11.22B | 45.91 | 30.73% | 9.12% | 18.12% | — | |
| $72.38 | $27.93B | 34.63 | 15.6% | 19.31% | 33.83% | — | |
| $15.42 | $1.06B | -5.07 | 7.93% | -9.2% | -68.29% | — | |
| $17.32 | $1.97B | -14.20 | 8.28% | -25.66% | -50.82% | — | |
| $93.40 | $3.21B | 32.32 | 7.57% | 7.67% | 8.23% | — | |
| $95.63 | $166.57B | 25.71 | 5.67% | 13.91% | 12.09% | — |
Insulet Corporation (PODD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Insulet Corporation (PODD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 6, 2026·SEC
Apr 29, 2026·SEC
Mar 12, 2026·SEC
Get notified when PODD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Insulet Corporation (PODD) stock FAQ — growth, dividends, profitability & financials explained
Insulet Corporation (PODD) reported $2.90B in revenue for fiscal year 2025.
Insulet Corporation (PODD) grew revenue by 30.7% over the past year. This is strong growth.
Yes, Insulet Corporation (PODD) is profitable, generating $302.8M in net income for fiscal year 2025 (9.1% net margin).
Insulet Corporation (PODD) has a return on equity (ROE) of 18.1%. This is reasonable for most industries.
Insulet Corporation (PODD) generated $412.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
